Ratings MicroTech Medical (Hangzhou) Co., Ltd.

Equities

2235

CNE100004QN6

Market Closed - Hong Kong S.E. Other stock markets 01:39:00 03/05/2024 pm IST			5-day change	1st Jan Change
4.1 ^HKD	+0.49%		+1.23%	-35.94%

27/03	MicroTech Medical Co., Ltd. Appoints Shi Yonghui as Joint Company Secretary	CI
27/03	MicroTech Medical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Strengths

Analysts expect a sharply increasing business volume for the group, with high growth rates in the coming years.
Thanks to a sound financial situation, the firm has significant leeway for investment.
The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Historically, the company has been releasing figures that are above expectations.

Weaknesses

As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
Low profitability weakens the company.
For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
Most analysts agree on a negative opinion with regard to the stock. Indeed, the average consensus issues recommendations to underperform or sell.
Over the past four months, analysts' average price target has been revised downwards significantly.
The overall consensus opinion of analysts has deteriorated sharply over the past four months.
Over the past twelve months, analysts' consensus has been significantly revised downwards.

Ratings chart - Surperformance

Sector: Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.	ESG Refinitiv
MICROTECH MEDICAL (HANGZHOU) CO., LTD.	-35.94%	221M	-
SHOCKWAVE MEDICAL, INC.	+73.37%	12.39B	B-
PENUMBRA, INC.	-17.09%	8.08B	C+
MASIMO CORPORATION	+16.88%	7.25B	C-
GETINGE AB	+3.57%	5.86B	B
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD.	+11.77%	5.35B	D+
APT MEDICAL INC.	+29.65%	4.63B	-
ASAHI INTECC CO., LTD.	-17.74%	4.19B	B-
INARI MEDICAL, INC.	-35.26%	2.44B	C
SKAN GROUP AG	+3.09%	2.07B	-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes